Tobramycin Injection
Product Images NDC 68083-241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 68083-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobramycin-spl-carton-label (Tobramycin Spl Carton Label)

Tobramycin-spl-carton-label (Tobramycin Spl Carton Label)
This is a description of Tobramycin Injection, USP in a pharmacy bulk package. The package contains 2g of tobramycin in 50mL, with a concentration of 40mg/mL. The medication is non-pyrogenic and the package should not be used for direct infusion. The text includes information on the manufacturer, Gian Pharma Limited, and the NDC number. There is also a caution to dilute the medication before use, and the package is not intended to be dispensed as a unit. The text includes additional information on the contents of the package and instructions for use.*
FDA Label Image

Tobramycin-spl-container-label (Tobramycin Spl Container Label)

Tobramycin-spl-container-label (Tobramycin Spl Container Label)
This text appears to contain some random and possibly unrelated text fragments, with no clear overarching theme or topic. There is mention of a medication called Tobramycin and some instructions regarding its preparation for intravenous use, but overall the text seems incoherent and not particularly useful.*
FDA Label Image

Tobramycin-spl-figure (Tobramycin Spl Figure)

Tobramycin-spl-figure (Tobramycin Spl Figure)
This text appears to be a table or chart showing the percentage of normal dosage based on creatinine clearance and serum creatinine levels. It is a reduced dosage nomogram, with values ranging from 0-70 mL/min/1.73 m² for creatinine clearance and 10-70 mg/100 mL for serum creatinine. The percentage of normal dosage appears to decrease with decreasing creatinine clearance and increasing serum creatinine levels.*
FDA Label Image

Tobramycin-spl-structure (Tobramycin Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.